SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11345282
Source:
http://linkedlifedata.com/resource/pubmed/id/11345282
Search
Subject
(
66
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0066700
,
umls-concept:C0087111
,
umls-concept:C0117996
,
umls-concept:C1960047
,
umls-concept:C1967611
,
umls-concept:C2347177
,
umls-concept:C2603343
pubmed:issue
4
pubmed:dateCreated
2001-5-9
pubmed:abstractText
Mometasone furoate (MF; Schering-Plough, Madison, NJ), is a glucocorticoid with high local potency and low potential systemic availability.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9503580
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Androstadienes
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Asthmatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Powders
,
http://linkedlifedata.com/resource/pubmed/chemical/Pregnadienediols
,
http://linkedlifedata.com/resource/pubmed/chemical/fluticasone
,
http://linkedlifedata.com/resource/pubmed/chemical/mometasone furoate
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1081-1206
pubmed:author
pubmed-author:BonnaudGG
,
pubmed-author:HaahtelaTT
,
pubmed-author:LunaJ MJM
,
pubmed-author:LutskyB NBN
,
pubmed-author:O'ConnorBB
,
pubmed-author:QuerfurtHH
,
pubmed-author:WegenerTT
pubmed:issnType
Print
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
397-404
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11345282-Administration, Inhalation
,
pubmed-meshheading:11345282-Adolescent
,
pubmed-meshheading:11345282-Adult
,
pubmed-meshheading:11345282-Aged
,
pubmed-meshheading:11345282-Androstadienes
,
pubmed-meshheading:11345282-Anti-Asthmatic Agents
,
pubmed-meshheading:11345282-Anti-Inflammatory Agents
,
pubmed-meshheading:11345282-Asthma
,
pubmed-meshheading:11345282-Chronic Disease
,
pubmed-meshheading:11345282-Dose-Response Relationship, Drug
,
pubmed-meshheading:11345282-Double-Blind Method
,
pubmed-meshheading:11345282-Forced Expiratory Volume
,
pubmed-meshheading:11345282-Humans
,
pubmed-meshheading:11345282-Male
,
pubmed-meshheading:11345282-Middle Aged
,
pubmed-meshheading:11345282-Nebulizers and Vaporizers
,
pubmed-meshheading:11345282-Powders
,
pubmed-meshheading:11345282-Pregnadienediols
,
pubmed-meshheading:11345282-Pulmonary Ventilation
,
pubmed-meshheading:11345282-Sleep Initiation and Maintenance Disorders
pubmed:year
2001
pubmed:articleTitle
Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
pubmed:affiliation
Department of Respiratory Medicine, Kings College Hospital, London, England. brian.o'connor@kcl.ac.uk
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study